(Q43582705)

24 November 2017

title

Restless legs syndrome (RLS) and periodic limb movement disorder (PLMD): acute placebo-controlled sleep laboratory studies with clonazepam (English)

1 reference

periodic limb movement disorder

24 November 2017

1 reference

1 reference

inferred from title

restless legs syndrome

1 reference

Saletu M

1

1 reference

24 November 2017

Anderer P

2

1 reference

24 November 2017

Saletu-Zyhlarz G

3

1 reference

24 November 2017

Prause W

4

1 reference

24 November 2017

Semler B

5

1 reference

24 November 2017

Zoghlami A

6

1 reference

24 November 2017

Gruber G

7

1 reference

24 November 2017

Hauer C

8

1 reference

24 November 2017

Saletu B

9

1 reference

24 November 2017

language of work or name

English

0 references

publication date

1 April 2001

1 reference

European Neuropsychopharmacology

24 November 2017

published in

1 reference

24 November 2017

volume

11

1 reference

24 November 2017

issue

2

1 reference

24 November 2017

page(s)

153-161

1 reference

Treatment of restless legs syndrome with gabapentin

24 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900080-3

7 January 2021

Sleep apnea and periodic movements in an aging sample.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900080-3

7 January 2021

The treatment of the restless legs syndrome with clonazepam: a prospective controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900080-3

7 January 2021

IPEG guideline on statistical design and analysis for pharmacodynamic trials. International Pharmaco-EEG Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900080-3

7 January 2021

Periodic leg movements in sleep following treatment of obstructive sleep apnea with nasal continuous positive airway pressure.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900080-3

7 January 2021

Carbamazepine in restless legs. A controlled pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900080-3

7 January 2021

Treatment of the restless legs syndrome with clonazepam

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900080-3

7 January 2021

Management of restless legs syndrome with gabapentin (Neurontin)

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900080-3

7 January 2021

Nocturnal myoclonus: treatment efficacy of clonazepam and temazepam.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900080-3

7 January 2021

Clonazepam and vibration in restless legs syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900080-3

7 January 2021

[The restless leg syndrome: a condition associated with periodic or aperiodic slowing of the EEG]

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900080-3

7 January 2021

Periodic leg movements in sleep: effect of clonazepam treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900080-3

7 January 2021

Clonazepam treatment of insomnia due to sleep myoclonus

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900080-3

7 January 2021

Double-blind evaluation of clonazepam on periodic leg movements in sleep

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900080-3

7 January 2021

Prevalence and risk factors of RLS in an elderly population: the MEMO study. Memory and Morbidity in Augsburg Elderly.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900080-3

7 January 2021

Is the subjectively experienced quality of sleep related to objective sleep parameters?

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900080-3

7 January 2021

Traffic Noise-Induced Sleep Disturbances and Their Correction by an Anxiolytic Sedative, OX-373

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900080-3

7 January 2021

Nocturnal traffic noise, sleep, and quality of awakening: neurophysiologic, psychometric, and receptor activity changes after quazepam.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900080-3

7 January 2021

Insomnia in generalized anxiety disorder: polysomnographic, psychometric and clinical investigations before, during and after therapy with a long- versus a short-half-life benzodiazepine (quazepam versus triazolam)

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900080-3

7 January 2021

Nonorganic insomnia in generalized anxiety disorder. 2. Comparative studies on sleep, awakening, daytime vigilance and anxiety under lorazepam plus diphenhydramine (Somnium) versus lorazepam alone, utilizing clinical, polysomnographic and EEG mappin

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900080-3

7 January 2021

Sleep laboratory studies in restless legs syndrome patients as compared with normals and acute effects of ropinirole. 1. Findings on objective and subjective sleep and awakening quality.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900080-3

7 January 2021

Sleep laboratory studies in restless legs syndrome patients as compared with normals and acute effects of ropinirole. 2. Findings on periodic leg movements, arousals and respiratory variables.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900080-3

7 January 2021

Sleep laboratory studies in periodic limb movement disorder (PLMD) patients as compared with normals and acute effects of ropinirole.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900080-3

7 January 2021

Nonorganic insomnia in panic Disorder: comparative sleep laboratory studies with normal controls and placebo-controlled trials with alprazolam.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900080-3

7 January 2021

The Babinski response and periodic limb movement disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900080-3

7 January 2021

Successful treatment of the idiopathic restless legs syndrome in a randomized double-blind trial of oxycodone versus placebo.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900080-3

7 January 2021

Toward a better definition of the restless legs syndrome. The International Restless Legs Syndrome Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900080-3

7 January 2021

Narcolepsy and disturbed nocturnal sleep.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900080-3

7 January 2021

10.1016/S0924-977X(01)00080-3

Identifiers

DOI

1 reference

24 November 2017

1 reference